On this week’s podcast we talk about further steps the US Medicare agency CMS is taking when it comes to expanding testing for COVID-19. We also discuss how the pandemic is wreaking havoc on planned meetings by the US FDA and industry groups.
Medtech Insight articles addressing topics discussed in this episode:
https://medtech.pharmaintelligence.informa.com/MT126702/CMS-Expands-Coronavirus-Testing-By-Allowing-NonPhysicians-To-Order-The-Diagnostics
https://medtech.pharmaintelligence.informa.com/MT126592/CMS-Doubles-Up-On-Test-Reimbursements-Will-Pay-Labs-100-Per-Test-For-COVID19-Clinical-Diagnostic-Ass
https://medtech.pharmaintelligence.informa.com/MT126648/Latest-Coronavirus-Bill-Passage-Adds-$100Bn-To-National-Testing-Effort
https://medtech.pharmaintelligence.informa.com/MT126602/MDUFA-Meeting-Postponed-Again-Due-To-COVID19-This-Time-Indefinitely
https://medtech.pharmaintelligence.informa.com/MT126679/No-End-In-Sight-FDA-Postpones-Another-InPerson-Meeting-Due-To-COVID19
https://medtech.pharmaintelligence.informa.com/MT126613/AdvaMed-CEO-Says-Some-Top-Agenda-Items-For-the-Year-Are-Taking-A-Back-Seat-To-Address-COVID19